Characterizing Malignant Tumors Using Ultrasound Doppler Imaging

Malignant Tumor of Women's Reproductive System Clinical Trial

Official title:

Characterizing Malignant Tumors Using Ultrasound Doppler Imaging

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03598335
• Other study ID #: HYMC-0096-17
• Status: Not yet recruiting
• Start date: July 2018
• Est. completion date: July 2019

Study information

• Verified date: July 2018
• Source: Hillel Yaffe Medical Center
• Contact: Genya Peisahov, BSc
• Phone: 972-54-8886349
• Email: genyap[@]hymc.gov.il
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is to determine whether Ultrasound Doppler imaging can identify malignant tumors at a very early stage.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: July 2019
• Est. primary completion date: July 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Women presenting for routine abdominal/vaginal ultrasound

Exclusion Criteria:

• Pregnant women

Related Conditions & MeSH terms

• Malignant Tumor of Women's Reproductive System
• Neoplasms

Intervention

Device:
• Ultrasound
Ultrasound imaging of women arriving at clinic for routine care

Locations

Country	Name	City	State
Israel	Hille Yaffe Medical Center	Hadera

Sponsors (1)

Lead Sponsor	Collaborator
Hillel Yaffe Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Early characterization of malignant tumors	Comparison of Ultrasound Doppler findings at different speeds between women without tumors, with benign tumors and with malignant tumors of reproductive system	One year